E Modifiers

E1

Upper left, eyelid

E2

Lower left, eyelid

E3

Upper right, eyelid

E4

Lower right, eyelid

EA

Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy

EB

Erythropoetic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy

EC

Erythropoetic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy

ED

Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

EE

Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle

EJ

Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab

EM

Emergency reserve supply (for esrd benefit only)

EP

Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program

ET

Emergency services

EX

Expatriate beneficiary

EY

No physician or other licensed health care provider order for this item or service